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M. SAN SEBASTIAN* AND G. H. BOTHAMLEY{
*London School of Hygiene and Tropical Medicine Keppel Street London WCIE 7HT and {East London
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This study explores the knowledge, attitudes and perception of tuberculosis (TB) and how they aect adherence to
preventive treatment.
A qualitative study of 24 subjects taking preventive therapy for TB was undertaken. Interviews were conducted in
English using a structured questionnaire in a private room adjoining the outpatient clinic before the subject’s
appointment. The questionnaire included; (i) demographic details; (ii) background information on TB; (iii)
knowledge and perception of TB and chemoprophylaxis. Data was analysed descriptively and thematically and
subjected to statistical evaluation where appropriate. Outcome was assessed 6 months after the start of preventive
treatment.
The sample was representative of the ethnic mix of those attending the clinic. Knowledge of TB was gained
outside the family and covered transmission but few symptoms of active TB were recognized. The perceived threat
from TB was high, although the estimated risk was low. Knowledge of preventive therapy exceeded the general
knowledge of TB, although the latter was associated with better adherence. Most denied knowledge of the risk of
hepatitis from isoniazid. Defaulters failed to attend their first appointment, attributed more side eects to isoniazid
and perceived a longer waiting time in clinic.
Adherence is better with a general knowledge of TB and attendance at the first appointment and could be
improved by a single daily tablet, warnings about dizziness and discussion of the diculties of taking a 6 month
course of treatment.
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Tuberculosis (TB) is on the increase in many countries and
there is little hope of reversing this trend unless serious
attention is paid to the human element, with consideration
of psychological attitudes to the disease at all levels of
society. This includes perception of the disease and its
therapy by subjects and their relatives as well as percep-
tions, priorities and motivating factors at governmental and
international levels (1). In the developed world, TB occurs
most frequently in members of deprived groups, which
include recent immigrants and ethnic minorities. A lack of
understanding of cultural dierences in attitudes to disease,
its diagnosis and therapy can be the cause of an
unintentional breakdown of trust, thereby leading to non-
compliance. Locally undertaken surveys on knowledge ofReceived 16 December 1998 and accepted in revised form 11 April
1999.
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0954-6111/00/070648+06 $35?00/0TB and attitudes towards the disease are therefore of
importance to the planning of control programmes (1).
Although it is well known that improving knowledge does
not necessarily lead to changes in attitude or behaviour,
measurement of knowledge and attitudes provides baseline
information for planners of health education programmes
(2).
In the U.K., preventive treatment is recommended for
those with a positive tuberculin reaction (Heaf grades 3 and
4) for school children prior to BCG vaccination (school
reactors), new arrivals under 35 years of age and contacts of
individuals with smear-positive pulmonary tuberculosis
aged 16 years or less and up to 35 years of age in high
risk groups (3,4). Guidelines issued after the present study
confirmed that school reactors should receive chemopro-
phylaxis if they had lived for the previous 2 years in an area
where the incidence of TB was 440 per 100 000 (5). The
American Thoracic Society recommends chemoprophylaxis
to all ‘tuberculin-positive individuals regardless of history
of vaccination with BCG’ (6). Preventive therapy is not
commonly used in low and middle income countries.# 2000 HARCOURT PUBLISHERS LTD
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have been made in other countries (2,7–10) and in the city
of Birmingham, U.K. (11). The aims of this study were: (i)
to obtain baseline information on knowledge and percep-
tions about TB and TB preventive therapy in a group of
subjects receiving chemoprophylaxis in the London Bor-
ough of Hackney; and (ii) to assess the influence of
knowledge and perceptions about TB and its preventive
therapy on adherence to a 6 month regimen of daily
isoniazid.
Materials and methods
STRUCTURED INTERVIEW
A questionnaire was designed to obtain information from
subjects on TB preventive therapy on: (i) demographic
details (age, gender, ethnicity, marital status, educational
and occupational levels, type of living arrangement and
number of people living at home); (ii) background
information on TB; (iii) knowledge and perception of TB
and (iv) chemoprophylaxis. The questionnaire contained 55
questions a combination of open-ended (eight) and direct
questions (26 yes/no/don’t know and 21 with other closed
categories for responses). The background information
included in the questionnaire consisted of items on prior
knowledge of TB and its source, a family history of TB and
knowing someone with TB, having family living in the area
and the relationship, if relevant, with the TB index case.
There were 10 yes/no/don’t know statements, one otherTABLE 1. Sociodemographic characteristics of the sample; Hom
Characteristic
Male
Age group 55
5–14
15–24
25–34
Ethnicity Sub–Saharan Africa
Turkish/Kurdish
White U.K.
S.E. Asia
Indian subcontinent
Latin America
Afro–Caribbean
Screening contact
school reactor
new arrival
BCG scar yes
no
unsure
Successful outcomedirect question and five open-ended questions on knowl-
edge and perceptions of TB, concerning the transmission,
cause and symptoms of the disease, concept of infection as
opposed to disease, adherence, seriousness, drug resistance,
treatment and prevention. The knowledge section of TB
preventive therapy concerning the perceived reasons for
taking isoniazid and side-eects of medication (seven direct
and two open), attitudes of family and friends towards
them and diculties with treatment compliance, including
access to health service (11 direct and one open). The
questionnaire was adapted from previous research tools
designed to measure knowledge, beliefs and attitudes
towards TB (7,9,11).
SETTING
The survey was carried out using the questionnaire
prepared and administered by the one of the authors.
Interviews were conducted in English by one of the authors
(MSS) whose first language was Spanish (one interview was
conducted in his first language). Before the survey, the
questionnaire was tested in a small pilot study and modified
slightly as a consequence. Respondents were interviewed in
a private room of the clinic while they were waiting for a
consultation with the doctor. The questionnaire took
approximately 15min to administer and all respondents
were interviewed individually or in the presence of an adult,
for instance the parent of school reactors. The content of
responses to all open-ended items was thoroughly explored
with advice from independent specialists (BG and JP) to
ascertain underlying common themes.erton Hospital, Hackney 1997 (n=24)
Sample
n=24 (%)
Not sampled
(n=32) (%)
Total
n=56
12 (50?0) 22 (68?8) 34
1 (4?2) 4 (12?5) 5
12 (50?0) 10 (31?3) 22
2 (8?3) 7 (21?9) 9
9 (37?5) 11 (34?4) 20
8 (33?3) 2 (37?5) 20
7 (29?2) 10 (31?3) 17
3 (12?5) 2 (6?3) 5
3 (12?5) 1 (6?3) 4
2 (8?3) 4 (12?5) 6
1 (4?2) 0 (0?0) 1
0 (0?0) 3 (9?4) 3
9 (37?5) 14 (43?8) 23
10 (41?7) 8 (25?0) 18
5 (20?8) 10 (31?3) 15
15 (62?5) 20 (62?5) 35
8 (33?3) 10 (31?3) 18
1 (4?2) 2 (6?2) 3
21 (87?5) 25 (78?1) 46
650 M. SAN SEBASTIAN AND G. H. BOTHAMLEYSAMPLE
All those taking chemoprophylaxis and attending the TB
clinic in the Homerton Hospital in the Borough of
Hackney, London, during the period 1 July to 31 August
1997 were eligible to enter the study. All individuals, or
their accompanying adult, who gave verbal consent to the
interview and who could communicate in English (or
Spanish — one subject) were included in the sample. The
sample was compared to those who did not participate in
the survey, but who attended the clinic during the same
period for ethnic mix, source and adherence to assess
generalizability (Table 1). School reactors were defined as
those with a positive tuberculin response before BCG
vaccination, new arrivals as those identified by the Port of
Health screening and coming from an area where TB was
common and contacts as tuberculin reactors who did not
have TB and who had been found by tracing those close to
an infectious case of TB.
All subjects were taking isoniazid for 6 months [BTS
guidelines (4)] and were seen at the start of treatment, after
2 weeks (or earlier if any side eects from the drug) and
thereafter at monthly intervals until the course had been
completed. At the start of treatment all subjects were told
of the possibility of hepatitis and peripheral neuropathy
and given a phone number to ring if there were any
problems. This advice is reinforced at every visit. Urine was
tested on each occasion for the presence of isoniazid (Difco
Laboratories Ltd, Surrey, U.K.) Good adherence was
defined by the presence of isoniazid on every occasion
tested and failure by the lack of attendance for the full 6
months; the remainder were classified as moderate adher-
ence.
ANALYSIS
The w2-test was used to describe dierences in frequencies,
and Fisher’s exact test used to determine the P-value. The
Mann–Whitney U-test was used to asses the significance of
dierences in knowledge scores and number of non-
attendances. Responses to open-ended questions were
analysed descriptively and thematically.
Results
SAMPLE
Twenty-four (12 females and 12 males) of the 56 individuals
taking preventive therapy at the TB clinic of the Homerton
Hospital participated in the study (Table 1). The sample
was representative of those invited to the clinic for
chemoprophylaxis during this period in sex, age, ethnicity
and previous BCG vaccination, although it included more
school reactors and fewer contacts and new arrivals
(w2=8?0, 3df, P50?05). A quarter of the non-‘White-
U.K.’ group had been born in U.K.; the median length of
stay in the country was 2 years (mean 4?7, range 4 months
to 25 years) for those not born in the U.K.BACKGROUND INFORMATION ON TB
Fifteen (63%) remembered having heard about TB before
starting chemoprophylaxis, indicating a medium level of
awareness. Five mentioned school as the source of
information, three the radio and/or a newspaper, but none
mentioned the health centre. Although nine contacts had a
current family history of TB and a further seven had family
members with a past history of TB, only one mentioned
that their relatives had provided any information about TB.
KNOWLEDGE AND PERCEPTIONS OF TB
Most of the sample were aware that TB was infectious (22/
24; 92%), although a smaller proportion agreed that TB
was spread ‘by breathing air someone with TB has coughed
in’ (63%). One thought TB was spread through food and
drink and six did not know how TB was transmitted. Three
(12.?5%) named ‘germs’ as the cause of TB. As for reasons
why some might be more susceptible to TB, one cited
smoking and another poor housing and eating. Only one of
the nine contacts didn’t know any of the symptoms of TB
compared to six of the 10 school reactors and two of the
five new arrivals. Cough was the most commonly recog-
nized symptom (10; 42%), but surprisingly only three
individuals considered coughing up blood a symptom of
TB. Only contacts mentioned night sweats or fever. Most
(88%) thought that TB could be easily treated, none
thought that TB could be cured spontaneously without
medical treatment, but all of them pointed to the necessity
of going to a hospital for treatment.
The perceived threat from TB was high — 17 (71%)
believed that TB was potentially fatal. However, the
majority felt that TB was uncommon in Hackney, that
complete recovery occurred after treatment and none had
heard about multidrug resistant TB. Although all respon-
dents were merely taking chemoprophylaxis and did not
have active TB, two had left their jobs because of their
treatment, one said that he had not told his friends or
family that he was taking any medicine and one student
noted that his teacher was ‘very angry’ that he was taking
preventative treatment for TB. Most preferred that friends
did not know anything about their situation. Two
respondents thought that their family was taking more
care of them and were worried or concerned. The prevailing
stigma attached to even preventative treatment for TB is
high.
Over half of the subjects (66?6%) suggested that TB was
preventable. In response to the open-ended question ‘how’,
only four (16?6%) mentioned BCG. Keeping warm and
eating properly (one), taking prophylaxis (one) and not
being close to a sick person (one) were mentioned as other
possible methods of prevention.
KNOWLEDGE AND PERCEPTIONS OF TB
PREVENTIVE THERAPY
Answers to the open-ended question ‘Do you know
why you are taking chemoprophylaxis this treatment’
ATTITUDES TO TUBERCULOSIS CHEMOPROPHYLAXIS 651were classified into four groups; (i) those who believed
that preventive therapy was needed in order to be
cured (12?5%), ‘to get rid of the TB’, (ii) those who
mentioned chemoprophylaxis as a measure of immediate
prevention, ‘I might get it soon’ (25%), (iii) those who
considered chemoprophylaxis necessary to avoid getting the
disease in the future, ‘I can get TB when I get older’
(45?8%) and (iv) those who did not seem to understand
the reason (16?7%), e.g. ‘because doctor said’ (two
individuals).
Four could not remember having received any explana-
tion from the hospital for their treatment; one school
reactor was at the end of her treatment and was unsure;
three were contacts from Turkey, Vietnam and Nigeria, of
whom the first two declined the help of an advocate
although their understanding of English was only fair. All
four gave completely correct answers to questions about the
reason for and duration of chemoprophylaxis. Few thought
that there was any danger associated with taking isoniazid;
only three mentioned the possibility of liver disease. Only
one had a symptom consistent with hepatitis, but had
normal liver function tests. Indeed liver function tests were
measured in individuals with any symptoms, all with
normal results. One defaulter reported dizziness but failed
to have his blood test.
Sex, age, marital status, ethnicity, place of birth, type of
living arrangement and number of people living at home,TABLE 2. Factors associated with adherence
Parameter
% urine 7ve for isoniazid/no of times tested 0
Non–attendance: before start of treatment
once treatment started
U.K. born
Problems: taking tablets every day
number of tablets
conflicting advice
before breakfast
none
TB knowledge score* 7
Chemoprophylaxis knowledge score{
Side–eects experienced 2
Travel time (mean+SD: min) 1
Perceived waiting time (min)
*TB knowledge score (Table 2), maximum score=12 (score for
a necessity for hospital treatment were not included in this sco
latter because of bias due to the sample setting.
{Chemoprophylaxis knowledge score [you have a positive TB
give TB to other? Do you know why you are taking this treatm
this treatment?]; maximum score of 5.
{Significant comparing Failed to Good and Fair adherence greducational level and employment status were not asso-
ciated with significant dierences in knowledge of TB or
preventative treatment. There was a trend for contacts to
have the most, and new arrivals the least, knowledge about
TB and preventative treatment, but this did not attain
statistical significance.
ADHERENCE TO A 6 MONTH COURSE OF
DAILY ISONIAZID
The rate of non-attendance for appointments at the TB
clinic was high (35?8%). Failure to attend at the first
appointment would have identified all defaulters, 27% of
those with moderate and 20% of those with good adherence.
There was a non-significant trend in the sample for new
arrivals to fail to complete preventative treatment for TB
more than school reactors or contacts which was confirmed
by analysis of the outcome in all those attending the clinic
during the 2 month period (w2=5?4. P50?05). In answer to
the question ‘What is the most dicult part about taking
the treatment’, the most common reply was the need to take
the tablets every day (Table 2). Several mentioned the
number of tablets; one had been given 50mg tablets by the
pharmacy which required six tablets to be taken every day,
rather than the standard 36100mg tablets. Those who
failed to adhere to the treatment regimen noted fewerLevel of adherence
Good
(n=10)
Moderate
(n=11)
Failed
(n=3)
?0+0?0 0?39+0?11 33?3+16?7
0(0–1) 0(0–3) 1(1–2)
1 (0–3) 1 (0–4) 4 (3–6){
5 1 0
7 8 0
3 1 0
2 0 0
0 2 0
1 0 3{
(2–11) 9 (3–12) 4 (2–6){
4 (2–5) 4 (3–5) 4 (4–4)
(20%) 4 (36%) 2 (67%)
8?7+5?2 22?8+5?1 13?3+4?4
30–60 30–60 460
symptoms limited to a maximum of 3): spontaneous cure and
re, the former because this knowledge was unhelpful and the
skin test, do you think you have (are sick with) TB? Can you
ent? (no. of items mentioned) How long do you have to take
oups combined, P50?05. Mann–Whitney U-test.
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two defaulters could specify the side-eects experienced.
None of the sample developed hepatitis or peripheral
neuropathy but almost one-third noted dizziness when
starting treatment which remitted within a few days. The
third defaulter, who did not experience any side-eects,
returned a year later having taken treatment for 3 months.
All three perceived a longer waiting time than those who
attended throughout the 6 months treatment. Knowledge
about TB rather than understanding of preventative
treatment appeared to correlate with successful completion
of chemoprophylaxis (Table 2).
Discussion
This study has shown that there is an important lack of
knowledge of the symptoms of TB and a significant threat
but low perceived risk from the disease. Adherence to
preventive treatment was better in those with a basic
understanding of TB rather than an understanding of
chemoprophylaxis itself and who were aware of the
diculties of taking treatment for 6 months.
In the treatment of TB, education and TB-related
knowledge were predictors of adherence (12–14). The
disparity between the basic knowledge about TB and the
specialized knowledge of preventive treatment suggests that
education oered by healthcare workers is oriented towards
treatment and not disease, with the aim of ensuring
compliance rather than addressing the public health issues
of prevention. In New York, only 40% of PPD positive
skin test intravenous drug users knew the dierence
between TB treatment and chemoprophylaxis (10), com-
pared to 75% in our sample; adherence was still only
moderate in the majority of our sample. Subjects might pay
greater attention to explanations that were personally
relevant (the course of treatment), being well and relieved
that they did not have the diagnosis of TB and not
remember or request broader information. This study does
not address the problem as to whether education received at
the start of treatment might improve adherence.
Reminder cards, monetary incentives, health education
by a visiting nurse or telephone call and supervision and
motivation of clinic sta have all been eective in
improving adherence to treatment for TB (15,16). Mone-
tary incentives cannot be given in the U.K. National Health
Service, but the perceived long waiting time in those who
did not adhere to treatment suggests that further measures
to improve motivation of the clinic sta might improve
adherence. This study also suggests that an awareness of the
diculties of taking tables for 6 months, or perhaps an
openness to discuss the problems might also be helpful. On
a more practical aspect, the wider use of a 300mg isoniazid
tablet (Hoescht Marion Rousell, Belgium — unlicensed in
the U.K.) might improve adherence. Considering the
number who reported dizziness, which was significantly
greater than previously reported (17), prior warning of this
self-limiting symptom might be valuable. Concerns about
side-eects clearly dominated the perceptions of those who
failed to complete the course of preventive treatment.Although the social stigma of TB was again documented,
its eect on adherence is unclear. The fear of death from TB
may have outweighed any fear of side-eects from the
treatment, especially in this healthy population for whom
any treatment would seem unnecessary. However, the eect
of knowing more about TB promoted adherence and
suggests that fear is not a good motivator!
Attendance and adherence are known to be linked, such
that the more frequently an appointment is missed, the
more likely non-adherence to treatment (18). If attendance
at the first appointment is taken as a reasonable predictor
of future adherence, than an alternative approach in these
individuals, such as radiographic examination at 3 and 12
months as recommended by the British Thoracic Society
(5), might be a more eective alternative for follow-up. A
shorter course of preventive treatment [(3 months of
rifampicin and isoniazid (5)] would not have greatly
increase adherence.
This study has shown that a more general knowledge of
TB is more helpful than merely an understanding of the
treatment regimen in promoting adherence. New findings
from this study recommend a single daily tablet, prior
warning of dizziness and an open discussion of the
problems of keeping to treatment for 6 months to
encourage adherence to preventive treatment.
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